**4. Behavioral outcomes**

Development of preclinical models of astrocyte dysfunction in SCZ is quickly expanding. We will summarize the existing animal models, which have relied on

altering key functions of astrocytes that have been discovered to be aberrant in SCZ. We will focus on genetic models. However, nongenetic preparations will be discussed in the case of modifying the astrocytes to trigger SCZ-like behavioral phenotypes. For further details, the readers are referred to the comprehensive review paper by Xia *et al.* [137].
